Can low vitamin B12 cause fatigue, cognitive impairment, mood symptoms, and neuropathic pain?

Low vitamin B12 status is a well-established contributor to a constellation of neurological and systemic symptoms, including fatigue, cognitive decline, mood disturbances, and neuropathic pain. These manifestations are particularly relevant in older populations, where B12 deficiency is more prevalent due to age-related changes in gastric absorption.

Clinical and effectiveness evidence

The clinical evidence linking vitamin B12 to these symptoms is robust, supported by both observational studies and intervention trials:

• Fatigue and Anemia: Low B12 is a primary cause of megaloblastic anemia, which reduces oxygen delivery to tissues. In geriatric populations, B12 levels below 400 pg/mL are significantly correlated with frailty and weakness.
• Cognitive Decline: Meta-analyses indicate that B-vitamin therapy (including B12) can slow the rate of brain atrophy by up to 30% in individuals with mild cognitive impairment (MCI). While it may not reverse advanced dementia, it is effective in slowing early-stage cognitive decline.
• Mood and Neuropathy: B12 deficiency is associated with a doubled risk of depression in older adults. In patients with diabetic neuropathy, supplementation has been shown to significantly reduce neuropathic pain scores (SMD: -0.39), reflecting its role in nerve repair.

Mechanistic explanations

The diverse symptoms of B12 deficiency arise from its role as a critical cofactor in two primary enzymatic pathways:

• One-Carbon Metabolism (SAMe Synthesis): B12 is essential for converting homocysteine to methionine, a precursor for S-adenosylmethionine (SAMe). SAMe is the universal methyl donor required for synthesizing neurotransmitters (serotonin, dopamine, and norepinephrine) and maintaining the myelin sheath that protects nerves. Deficiency leads to "methyl trap" issues, resulting in mood symptoms and nerve demyelination (neuropathic pain).
• Mitochondrial Energy Production: B12 is a cofactor for methylmalonyl-CoA mutase, which facilitates the entry of fuel into the Krebs cycle for ATP production. Deficiency causes an accumulation of methylmalonic acid (MMA) and reduced cellular energy, explaining why fatigue can occur even in the absence of anemia.
• Neuroprotection: Elevated homocysteine levels—a hallmark of B12 deficiency—are directly neurotoxic, promoting oxidative stress and white matter hyperintensities in the brain.

Bottom line

Low vitamin B12 is a scientifically supported cause of fatigue, cognitive impairment, mood symptoms, and neuropathic pain. These effects occur through impaired oxygen transport, disrupted neurotransmitter synthesis, and the degradation of protective nerve coatings (myelin). Screening and supplementation are highly effective, particularly for preventing the progression of early cognitive and neurological symptoms.